EUnetHTA startpage / Public / Activities / EUnetHTA Joint Action 2010-12

EUnetHTA Joint Action 2010-12

The overarching objective of the EUnetHTA Joint Action (JA) is to put into practice an effective and sustainable HTA collaboration in Europe that brings added value at the European, national and regional level. Download the Technical Annex of the Grant Agreement with the Commission (2009 23 02 – EUnetHTA Joint Action) (Tech Annex Part 1, Tech Annex Part 2).

Specific Objectives

Number	Title	Description
1	Development of a general strategy and a business model for sustainable European collaboration on HTA	Construction of a business model for collaboration addressing the sustainability of the HTA collaboration within EU.
2	Development of HTA tools and methods	Develop principles, methodological guidance as well as functional online tools and policies for – producing, publishing, storing and retrieving structured HTA information and Core HTAs (including a new application of the Core HTA Model structure in screening) – improved Relative Effectiveness Assessment (REA) by identifying areas where methodological guidance is needed and by providing it, suggesting ways to integrate REA of pharmaceuticals as a special version of the HTA Core Model – structured exchange and storage of information on evidence generation on new technologies (data requirements following HTA, planned, ongoing, or completed data collection, e.g. registries and clinical trials).
3	Application and field testing of developed tools and methods	Test and implement - a web-based toolkit for structured exchange and storage of information on evidence generation on new technologies - application of the Core HTA model in common production of at least 2 Core HTAs - a REA of (a group) of pharmaceuticals in line with the core HTA development - real life support of information flow on new technologies prompting those where parallel assessments of same technologies are detected and alerting on opportunities for information sharing and closer collaboration (3 specific collaborations on new technologies coordinated). - provision of a contemporary information management system which ensures compatibility and interoperability across WPs’ tools to support collaborative HTA work, and ensure rapid dissemination of HTA results within the JA.

Deliverables

Number	Title	Description	Confidentiality level	Month of delivery
1	a) An online Tool & Service for producing, publishing, storing and retrieving HTA information. b) HTA Core Model on screening	a) It facilitates the use of the paper-based HTA Core Model developed previously, allowing to produce, publish, store and retrieve Core HTAs and other HTA information not included in Core HTAs. It supports production of local reports using Core HTAs. b) a new application of the HTA Core Model	Public	a) December 2012 b) March 2011
2	A set of 2 Core HTAs	Two completely new Core HTAs on topics that are pertinent to several HTA agencies and that can be utilized when producing local HTA reports on the same topics	Public	December 2012
3	A methodological guidance that will be appropriate for the assessment of relative effectiveness of pharmaceuticals	A common methodology for the relative effectiveness assessment (REA) of pharmaceuticals consisting of a tutorial that describes the fundamental principles of REA and a toolbox that can be used in daily practice for REA in standardized fashion	Public	December 2012
4	Operational web-based toolkit including database containing information on evidence generation on new technologies	Database including information on - questions that deserve additional evidence generation (AEG), - technologies with (conditional approval) requirements for AEG, - planned, ongoing or completed collection of data, e.g. (pragmatic) clinical trials	Public for certain areas /EUnetHTA JA partners for all areas	September 2012
5	Quarterly communication protocol for information flow on ongoing/planned national assessments of same technologies	Protocols containing information on ongoing/planned national assessments of identical and therefore alerted topics, to facilitate the analysis of hindrances and chances of collaboration on specific topics	scientific community only/Access rights	December 2012
6	Information Management System (IMS) and the related documentation, processes and policies	The IMS provides a single point of access - ensuring compatibility - to resources that help to conduct HTA, with emphasis on automation of the content update processes	Public /Access rights to certain areas	September 2012
7	Communication and Dissemination Plan	Building on the communication strategy developed during EUnetHTA 2006-08 Project, an elaborated Communication and Dissemination Plan will be written and implemented as part of the JA	Confidential	June 2011
8	Stakeholder Policy	Development of a stakeholder involvement policy	Public	October 2010
9	Collaboratively developed business model for sustainability	Development of a collaborative business model for sustainability	Public	December 2011
10	A relative effectiveness assessment of a (group of) pharmaceutical(s)	As a part of methodological guidance development and in line with the core-HTA development	Public	March 2012
11	Final Report from the Joint Action	Final report including evaluation results	Public	December 2012